GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver

NCT04546022 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Galactose Single Point (GSP), Residual Liver Function

Interventions

DRUG: Drug: G.S.P. Solution 400 mg/ml I.V. 1.25 ml/kg BW G.S.P. solution after fasting for 6 hours.

Sponsor

National Defense Medical Center, Taiwan

Collaborators

[object Object]
[object Object]